MétaCan
Menu
Back to cohort
Record W4414466009 · doi:10.1158/2326-6074.cimm25-a019

Abstract A019: Timed intracranial therapy with NK cells and NK cell-derived extracellular vesicles following temozolomide exhibits curative potential in mesenchymal glioblastoma model

2025· article· en· W4414466009 on OpenAlexaffabout
Brian Meehan, Lata Adnani, Xianbing Zhu, Nadim Tawil, Victor Yip, Fang Cheng Wong, Delphine Garnier, Ichiro Nakano, Sidong Huang, Janusz Rak

Bibliographic record

VenueCancer Immunology Research · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicExtracellular vesicles in disease
Canadian institutionsMcGill UniversityMcGill University Health Centre
Fundersnot available
KeywordsTemozolomideGliomaMesenchymal stem cellImmunotherapyNKG2DIn vivoImmune systemChemotherapyCD8Tumor microenvironment

Abstract

fetched live from OpenAlex

Abstract Glioblastoma (GBM) is an incurable brain cancer driven by tumor-initiating glioma stem cells (GSCs). GSCs are heterogenous in that they exhibit transcriptomes resembling either proneural (PN) or mesenchymal (MES) subtypes of GBM. Residual deposits of GSCs are thought to trigger inevitable relapse of GBM following surgery, radiation and temozolomide (TMZ) chemotherapy in the absence of robust immune infiltration and surveillance. Here we explore and exploit our observation that GSC subtypes differ dramatically in their sensitivity to NK mediated killing. Thus, MES-GSCs (unlike PN-GSCs) are enriched in ligands for NKG2D receptors (MICA, MICB, ULBP2-5) and are efficiently killed by NK92MI human NK cells in vitro. Markers of NK cell sensitivity also correlate with the MES subtype of GBM in large transcriptomic datasets (TCGA). While neither endogenous NK cells, nor exogenously injected intracranial NK92MI cells eradicate MES-GSC tumors, pre-treatment of tumor bearing mice with TMZ and the resulting onset of tumor repopulation renders subsequent NK therapy curative in the case of MES-GSC xenografts, but not in their PN-GSC counterparts. These curative effects of NK92MI cells are retained following their irradiation, which also results in complete growth arrest and gradual elimination of these cells from the site of their intracranial inoculation. Delay in injection of NK92MI cells beyond 14 days post TMZ administration erodes their curative potential in MES-GSC tumors due to the onset of post chemotherapy tumor regrowth. Notably, the NK effector expression and tumor killing activity in vitro and in vivo is retained in preparations of extracellular vesicle (EV)-enriched supernatants (VES) from NK92MI cell cultures. Thus, our data suggest that timed chemotherapy may have a potential to modify effector:target ratio in GBM tumors in vivo rendering the NK-sensitive tumor subtypes susceptible to immunological eradication. Moreover, NK cell derived EVs (or VES preparations) may present themselves as potential off-the-shelf therapeutics to treat currently incurable cancers, such as GBM. Citation Format: Brian G. Meehan, Lata Adnani, Xianbing Zhu, Nadim G. Tawil, Victoria Yip, Fang Cheng Wong, Delphine Garnier, Ichiro Nakano, Sidong Huang, Janusz Rak. Timed intracranial therapy with NK cells and NK cell-derived extracellular vesicles following temozolomide exhibits curative potential in mesenchymal glioblastoma model [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity; 2025 Sep 24-27; Montreal, QC, Canada. Philadelphia (PA): AACR; Cancer Immunol Res 2025;13(9 Suppl):Abstract nr A019.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.037
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.309
Teacher spread0.293 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueCancer Immunology ResearchSame topicExtracellular vesicles in diseaseFrench-language works237,207